Literature DB >> 28783385

Candida auris: a worrisome, globally emerging pathogen.

Bhagyashri D Navalkele1, Sanjay Revankar2, Pranatharthi Chandrasekar3.   

Abstract

INTRODUCTION: Candida auris is a recently discovered, rapidly emerging fungal pathogen. Infections due to C. auris are hospital-acquired, multidrug resistant and associated with high mortality. Areas covered: This review highlights epidemiology, pathogenesis, microbiological characteristics, clinical presentation, diagnostic challenges and treatment options of C. auris infections. Infection prevention measures to prevent spread of C. auris and special measures during an outbreak situation have also been reviewed. Expert commentary: Rapid emergence of hospital onset C. auris is worrisome. Early diagnosis of C. auris is essential for better outcomes and the implementation of infection prevention measures. Lack of widespread awareness, absence of general availability of diagnostic testing methods, and limited options for treatment of C. auris infections make it a difficult-to-treat pathogen. Further studies are needed for better understanding of this emerging pathogen.

Entities:  

Keywords:  C. auris; Candida; Candidemia; Fungal infection; bloodstream infection

Mesh:

Substances:

Year:  2017        PMID: 28783385     DOI: 10.1080/14787210.2017.1364992

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  18 in total

1.  Preparing your healthcare facility for the new fungus among us: An infection preventionist's guide to Candida auris.

Authors:  Tina Z Wang; Kindra N White; Jillian Villani Scarr; Matthew S Simon; David P Calfee
Journal:  Am J Infect Control       Date:  2020-07       Impact factor: 2.918

2.  Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method.

Authors:  Marie Helleberg; Karin Meinike Jørgensen; Rasmus Krøger Hare; Raluca Datcu; Anuradha Chowdhary; Maiken Cavling Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Polyphenol-Capped Biogenic Synthesis of Noble Metallic Silver Nanoparticles for Antifungal Activity against Candida auris.

Authors:  Maqsood Ahmad Malik; Maha G Batterjee; Majid Rasool Kamli; Khalid Ahmed Alzahrani; Ekram Y Danish; Arshid Nabi
Journal:  J Fungi (Basel)       Date:  2022-06-16

Review 4.  Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology.

Authors:  Hasti Kamali Sarvestani; Alireza Ramandi; Muhammad Ibrahim Getso; Taraneh Razavyoon; Javad Javidnia; Miaad Banay Golrizi; Ali-Akbar Saboor-Yaraghi; Saham Ansari
Journal:  Braz J Microbiol       Date:  2022-03-28       Impact factor: 2.214

5.  Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.

Authors:  Virginia Basso; Angie Garcia; Dat Q Tran; Justin B Schaal; Patti Tran; Diana Ngole; Younus Aqeel; Prasad Tongaonkar; André J Ouellette; Michael E Selsted
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 6.  Candida auris: A Quick Review on Identification, Current Treatments, and Challenges.

Authors:  Lucia Černáková; Maryam Roudbary; Susana Brás; Silva Tafaj; Célia F Rodrigues
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 7.  Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.

Authors:  Siang Fei Yeoh; Tae Jin Lee; Ka Lip Chew; Stephen Lin; Dennis Yeo; Sajita Setia
Journal:  Infect Drug Resist       Date:  2018-05-30       Impact factor: 4.003

8.  Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.

Authors:  Ahmed Gamal; Lisa Long; Janet Herrada; Jalal Aram; Thomas S McCormick; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

9.  Retrospective Analysis of the Clinical Characteristics of Candida auris Infection Worldwide From 2009 to 2020.

Authors:  Shan Hu; Feilong Zhu; Weiwei Jiang; Yuehua Wang; Yongqiang Quan; Guoming Zhang; Feng Gu; Ying Yang
Journal:  Front Microbiol       Date:  2021-05-20       Impact factor: 5.640

Review 10.  The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future.

Authors:  Gloria Hoi Wan Tso; Jose Antonio Reales-Calderon; Norman Pavelka
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.